Maelstrom Research Staging | RECOVER_Phase_2_COVID19_naïve_group-29_2_days_post_dose

RECOVER_Phase_2_COVID19_naïve_group_29_2_days_post_dose_1

Networks -

Variables -

Associated study RECOVER Contingency Table

Population

RECOVER - Phase 2 COVID-19 naïve group

The population is composed of healthcare workers who will receive a COVID-19 vaccine and have not previously been infected with COVID-19 (no history of a positive PCR and negative serology at recruitment) before their vaccination. Participants receive their vaccinations around the same times as the phase 2 COVID-19 subgroup.

Selection Criteria

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Participants must not have any history of SARS-CoV-2 infection nor the presence of anti-N or anti-RBD antibodies against SARS-CoV-2 at recruitment.

Other Criteria

Participants must be health care workers.

Recruitment

Sources of recruitment

Specific population

Specific Population

Members of an association

Number of Participants

Number of Participants: 39
Number of Participants with Biological Samples: 39

More info

Data Collection Event

RECOVER - Phase 2 COVID-19 naïve group - 29 days post dose 1

Blood samples are collected 29 ± 2 days post dose 1.

More info

Collected Dataset / RECOVER_Phase_2_COVID19_naïve_group-29_2_days_post_dose_1

RECOVER_Phase_2_COVID19_naïve_group_29_2_days_post_dose_1

Population

RECOVER - Phase 2 COVID-19 naïve group

Data Collection Event

RECOVER - Phase 2 COVID-19 naïve group - 29 days post dose 1

Files

Variables Classifications